Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9173490 | Journal of Vascular Surgery | 2005 | 8 Pages |
Abstract
Endotension in the absence of a demonstrable endoleak has been a major indication for late surgical conversion in patients treated with the Excluder endograft. Given the potential presence of an undetected endoleak and the possible effects of progressive sac enlargement on long-term device stability, continued close surveillance of patients with assumed endotension is required. Should changes in device design eliminate endotension, a further reduction in the already low incidence of late open conversion of the Excluder endograft can be anticipated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Li Sheng MD, Douglas MD, Karthik MD, Ross MD, Thomas F. MD, Atef A. MD, Robert B. MD, Elliot L. MD, PhD,